Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Arq. bras. oftalmol ; 72(2): 189-193, mar.-abr. 2009. graf, tab
Artículo en Inglés | LILACS | ID: lil-513887

RESUMEN

Purpose: To evaluate the prediction of refraction using the SRK/T formula for intraocular lens (IOL) calculation in eyes with medium axial length after phacoemulsification. Methods: This prospective study enrolled 33 eyes with nuclear cataract that underwent phacoemulsification. All procedures were performed by one surgeon with theintraocular lens placed within the capsular bag. The same technician whowas unaware of the purpose of the study made all the measurements. Theachieved refractive error one month after surgery was compared to the predicted postoperative refractive error by the SRK/T formula. Results: The ocular axial length varied between 22.2 mm and 24.5 mm. The mean predicted refraction was -0.431 ± 0.181 D and the mean achieved postoperative spherical equivalent was -0.220 ± 0.732 D. Eighteen eyes (55%) had a refractive error between ± 0.50 D and thirty eyes (91%) between ± 1.00 D of the predicted refraction. There was a tendency toward hyperopic shift (mean ± SD: 0.211 ± 0.708 D, p=0.009). Conclusion: The SRK/T formula demonstrated a satisfactory accuracy to calculate the error of refraction in eyes with medium axial length.


Objetivo: Avaliar resultados refracionais utilizando a fórmula SRK/T no cálculo de lentes intraoculares (LIO) em olhos comcomprimento axial médio após facoemulsificação. Métodos: Este estudo prospectivo envolveu 33 olhos com catarata nuclear que foram submetidos a facoemulsificação. Todas as cirurgias foram realizadas pelo mesmo cirurgião com lentes intraoculares no saco capsular. O mesmo tecnólogo, o qualnão sabia o objetivo do estudo, realizou todas as medidas biométricas. O erro refracional atingido um mês após a cirurgia foi comparado ao erro refracional pós-operatório previsto pelafórmula SRK/T. Resultados: O comprimento axial variou entre 22,2 mm e 24,5 mm. A refração média prevista foi -0,431 ± 0,181 dioptrias (D) e o equivalente esférico pós-operatório alcançado foi -0,220 ± 0,732 D. Dezoito olhos (55%) obtiveram errorefracional de ± 0,50 D e 30 olhos (91%) entre ± 1,00 D da refração prevista. Houve tendência a um erro hipermetrópico (média±SD: 0,211 ± 0,708 D, p=0,009). Conclusão: A fórmula SRK/T demonstrou acurácia satisfatória no cálculo do erro refracional em olhos de comprimento axial médio.


Asunto(s)
Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Implantación de Lentes Intraoculares , Facoemulsificación/métodos , Valor Predictivo de las Pruebas , Estudios Prospectivos , Refractometría , Reproducibilidad de los Resultados , Resultado del Tratamiento , Agudeza Visual
2.
Arq. bras. oftalmol ; 64(2): 147-151, mar.-abr. 2001. tab
Artículo en Inglés | LILACS | ID: lil-286038

RESUMEN

Purpose: To evaluate and compare the in vitro susceptibility of human conjunctival bacterial isolates to various antimicrobial agents, including lomefloxacin, other fluoroquinolones (ciprofloxacin, norfloxacin, and ofloxacin), aminoglycosides (gentamicin, tobramycin, and amicacin), and cephalosporin ( cephalothin). Methods: Antibiotic susceptibility tests conducted over a period of 27 months with 613 bacterial isolates from the conjunctiva were retrospectively analyzed.Results to the total number of positive isolates, the fluoroquinolones showed greater in vitro effectiveness than the other analyzed antibiotics. All bacterial isolates showed significantly higher susceptibility to ciprofloxacin than to lomefloxacin. Conclusion: the fluoroquinolones are not only equally effective against all conjunctival bacterial isolates but they also show superior antimicrobial activity in comparison to aminoglycosides and cephalothin. These results suggest that fluoroquinolones, such as lomefloxacin, can be beneficially prescribed for conjunctival infections and also as prophylaxis in ocular surgery.


Asunto(s)
Antiinfecciosos/uso terapéutico , Enfermedades de la Conjuntiva/microbiología , Técnicas In Vitro , Aminoglicósidos/uso terapéutico , Antiinfecciosos/uso terapéutico , Profilaxis Antibiótica , Cefalosporinas/uso terapéutico , Enfermedades de la Conjuntiva/tratamiento farmacológico , Infecciones Bacterianas del Ojo/tratamiento farmacológico , Estudios Retrospectivos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA